Abstract

Which virological factors mediate overdispersion in the transmissibility of emerging viruses remains a long-standing question in infectious disease epidemiology. Here, we use systematic review to develop a comprehensive dataset of respiratory viral loads (rVLs) of SARS-CoV-2, SARS-CoV-1 and influenza A(H1N1)pdm09. We then comparatively meta-analyze the data and model individual infectiousness by shedding viable virus via respiratory droplets and aerosols. The analyses indicate heterogeneity in rVL as an intrinsic virological factor facilitating greater overdispersion for SARS-CoV-2 in the COVID-19 pandemic than A(H1N1)pdm09 in the 2009 influenza pandemic. For COVID-19, case heterogeneity remains broad throughout the infectious period, including for pediatric and asymptomatic infections. Hence, many COVID-19 cases inherently present minimal transmission risk, whereas highly infectious individuals shed tens to thousands of SARS-CoV-2 virions/min via droplets and aerosols while breathing, talking and singing. Coughing increases the contagiousness, especially in close contact, of symptomatic cases relative to asymptomatic ones. Infectiousness tends to be elevated between 1 and 5 days post-symptom onset. Intrinsic case variation in rVL facilitates overdispersion in the transmissibility of emerging respiratory viruses. Our findings present considerations for disease control in the COVID-19 pandemic as well as future outbreaks of novel viruses. Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant program, NSERC Senior Industrial Research Chair program and the Toronto COVID-19 Action Fund.

Highlights

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally, causing the coronavirus disease 2019 (COVID-19) pandemic with more than 129.2 million infections and2.8 million deaths (Dong, Du, & Gardner, 2020)

  • The analyses indicate heterogeneity in respiratory viral loads (rVLs) as an intrinsic virological factor facilitating greater overdispersion for SARS-CoV-2 in the COVID-19 pandemic than A(H1N1)pdm09 in the 2009 influenza pandemic

  • Our findings present considerations for disease control in the 42 COVID-19 pandemic as well as future outbreaks of novel viruses

Read more

Summary

Introduction

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally, causing the coronavirus disease 2019 (COVID-19) pandemic with more than 129.2 million infections and2.8 million deaths (as of 1 April 2021) (Dong, Du, & Gardner, 2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally, causing the coronavirus disease 2019 (COVID-19) pandemic with more than 129.2 million infections and. Aerosols (≤100 μm) can be inhaled nasally, whereas droplets (>100 μm) tend to be excluded (Prather et al, 2020; Roy & Milton, 2004). Droplets must be sprayed ballistically onto susceptible tissue (Liu, Li, Nielsen, Wei, & Jensen, 2017). Aerosols can be further categorized based on typical travel characteristics: short-range aerosols (50-100 μm) tend to settle within 2 m; long-range ones (10-50 μm) often travel beyond 2 m based on emission force; and buoyant aerosols (≤10 μm) remain suspended and travel based on airflow profiles for minutes to many hours Which virological factors mediate overdispersion in the transmissibility of 23 emerging viruses remains a longstanding question in infectious disease epidemiology

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call